Catalyst Wire Dossier Catalyst Wire Dossier

OTX-TIC

· Ocular Therapeutix, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OTX-TIC, covering 2024-10-01 to 2024-10-01. Get the full timeline:

Most recent: Clinical Trial Update: CLN-0045: Safety, and Efficacy of OTX-TIC in Participants With Open Angle Glaucoma or Ocular Hypertension [Phase 1]

See pricing